Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
about
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.Plasmodium falciparum specific helicase 3 is nucleocytoplasmic protein and unwinds DNA duplex in 3' to 5' direction.Introduction to the Special Issue on Malaria.Induction of high tolerance to artemisinin by sub-lethal administration: A new in vitro model of P. falciparum.Artesunate shows potent anti-tumor activity in B-cell lymphoma.Targeting Channels and Transporters in Protozoan Parasite Infections.Biotechnological approaches for artemisinin production in Artemisia.Artemisinin Prevents Glutamate-Induced Neuronal Cell Death Via Akt Pathway Activation.
P2860
Q40106428-7A7D2524-BEC9-432A-AC64-600C6643758BQ42377173-DDE731EA-F32E-431D-889A-A7EBD954248CQ47762506-06BBE853-FE4B-4AC7-9C14-4C3B43F61D41Q48022305-581B239F-0A5C-493D-A3AE-7D90CD60B557Q49843417-91190B28-7952-42AF-8E16-9E95079C7CD3Q52594992-CC2651CD-F65A-4C3F-8437-A6E3A699EF08Q52626359-D7F031CE-6CA2-49F3-AF56-578C4AAD3766Q55334239-E195D770-B6DD-43BD-B6BF-0F9AA781D8D0
P2860
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
@en
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
@nl
type
label
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
@en
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
@nl
prefLabel
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
@en
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
@nl
P2860
P356
P1433
P1476
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
@en
P2093
Jan B Koenderink
Reginald A Kavishe
P2860
P304
P356
10.1111/FEBS.14097
P407
P577
2017-05-03T00:00:00Z